Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Inactive dipeptidyl peptidase 10 (DPP10) is a single-pass type II membrane glycoprotein of the S9B serine protease subfamily, rendered enzymatically inactive by the substitution of a catalytic serine in its active site[1][3]. Despite lacking protease function, DPP10 serves as an essential auxiliary subunit that binds to and modulates the biophysical properties, expression, and localization of specific voltage-gated potassium channels, particularly Kv4.x family members[1][2]. DPP10’s activity influences neuronal excitability and airway epithelial physiology; it has key roles in regulating ion channel gating kinetics and facilitating cell surface localization of the channels[1][2][3]. Genetic variants or mutations in DPP10 are associated with asthma, neurodegenerative diseases (including Alzheimer’s and frontotemporal dementia), and autism spectrum disorders[2][3]. The absence of protease activity makes DPP10 unique among dipeptidyl peptidases, and its primary molecular role is in protein-protein interaction rather than catalysis[1][2][3]. There are currently no approved drugs known to interact directly with DPP10, nor established clinical biomarkers or mechanisms of action through inhibition/activation, but the protein is being studied for its role as a modulator of ion channel complexes and as a biological link to respiratory and neurological conditions[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Inactive dipeptidyl peptidase 10 (DPP10).